Microbiology & Infectious Diseases

Study of 2,061 infants reveals RSV, HMPV, influenza, and viral co-infections significantly increase severe lower respiratory illness risk.

Children face over twice the risk of paediatric long COVID after SARS-CoV-2 reinfection, highlighting urgent needs for prevention.

A USA cohort study finds persistent olfactory dysfunction up to 2 years after COVID-19, even in people unaware of smell loss.

New study shows oral microbiome imbalance and reduced salivary hypotaurine may contribute to neuroinflammation in relapsing-remitting MS.

EACS 2025 study shows doxycycline prophylaxis reduced chlamydia and syphilis rates in Swiss men with HIV, with no effect against gonorrhoea.

EACS 2025 data show over half of HIV diagnoses among migrants in Switzerland occur post-migration, highlighting need for targeted testing and prevention.

EACS 2025 study shows minimal HBV reactivation after stopping tenofovir in people with HIV, supporting safe use of tenofovir-sparing ART.

New EACS data show once-weekly islatravir and lenacapavir maintain HIV viral suppression for 96 weeks with no resistance or major side effects.